# anvajo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/anvajo

- Industry: Medical Devices & Equipment
- Headquarters: Dresden, Germany
- Website: www.anvajo.com
- Total disclosed funding: $17M
- Latest round: Series A (Oct 13, 2022)
- Investors on record: 5

## About

Based in Dresden, Germany, and founded in 2016 by its CTO, Stefan Fraedrich, Anvajo GmbH, a spin-off diagnostic company from Dresden University of Technology, operates as a developer and manufacturer of monitoring devices providing point-of-care solutions for laboratory diagnostics. In October 2022, anvajo GmbH raised EUR 17.7 million in series A funding from investors, Elber Beteiligungen, Johnsoville Ventures, Medice Arzneimittel, and Think.Health Ventures, with participation from returning investor Die Bruckenkopfe. As of 2022, the company is led by its CEO, Stefan Fraedrich.

The company offers a healthcare platform for fluid analysis that includes the sampling of liquids like blood, urine, sperm, and water. The company uses holographic microscopy, machine-learning-supported image analysis, mobile embedded hardware, function-integrated optics, and meso-and microfluidic sample carriers. Its product portfolio includes fluidlab R-300. vet fluidlab 1, acella, and datalab. . Its product portfolio includes the Acella sample carrier platform, a glass-based proprietary format designed for small liquid volumes and microscopic applications such as cell culture analysis and body fluid examination. Acella variants include Acella 50, Acella 100, and a veterinary urine-specific Acella carrier, all compatible with standard and fluorescence microscopes.

## Funding rounds

- Series A, Oct 13, 2022, $17M — Think.Health Ventures, Die Bruckenkopfe, Medice Arzneimittel, Johnsoville Ventures, Elber Beteiligungen

## Investors

- Think.Health Ventures (https://capitalatlas.ai/funds/think-health-ventures) — Series A
- Die Bruckenkopfe (https://capitalatlas.ai/funds/die-bruckenkopfe) — Series A
- Medice Arzneimittel — Series A
- Johnsoville Ventures — Series A
- Elber Beteiligungen — Series A